The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

[1]  R. Brand,et al.  Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Ganser,et al.  Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. , 2010, Blood.

[3]  A. Gratwohl,et al.  The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies , 2009, Bone Marrow Transplantation.

[4]  S. Forman.  What is the role of reduced-intensity transplantation in the treatment of older patients with AML? , 2009, Hematology. American Society of Hematology. Education Program.

[5]  R. Soiffer,et al.  Variation in supportive care practices in hematopoietic cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  R. Soiffer,et al.  Individual physician practice variation in hematopoietic cell transplantation. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  F. Appelbaum,et al.  Hematopoietic-cell transplantation at 50. , 2007, The New England journal of medicine.

[8]  D. Blaise,et al.  Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. , 2007, Haematologica.

[9]  N. Schmitz,et al.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.

[10]  J. Esteve,et al.  Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) , 2005, Leukemia.

[11]  D. Blaise,et al.  The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison , 2005, Leukemia.

[12]  J. Klein,et al.  Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. , 2005, Blood.

[13]  J. Golmard,et al.  Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France , 2004, Bone Marrow Transplantation.

[14]  A. Gratwohl,et al.  Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey , 2002, Bone Marrow Transplantation.

[15]  K. Matsuo,et al.  Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation , 2000, Bone Marrow Transplantation.

[16]  J. Sierra,et al.  Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia , 2000, The Lancet.

[17]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[18]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[19]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[20]  E. Estey,et al.  Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. , 1997, Blood.

[21]  A. Rimm,et al.  Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? , 1992, Blood.